Logo Image
News|Articles|July 2, 2025

Seegene Launches STAgora Platform to Support Real Time Infectious Disease Tracking

The new platform integrates PCR-based diagnostic data with statistical modeling and AI to provide real-time visibility into infectious disease trends at local and global levels.

Key Takeaways

Real-Time Infectious Disease Monitoring: STAgora integrates PCR diagnostic data to provide immediate visualization and tracking of outbreaks at municipal, national, and global levels.

AI-Driven Predictive Analytics: The platform uses advanced AI algorithms and over 40 statistical tools to forecast disease spread and detect abnormal pathogen patterns early.

Seamless Integration with Automated PCR Systems: STAgora is designed to work alongside Seegene’s Cureca, enabling comprehensive automation from sample processing to data analysis for improved clinical decision-making.

Seegene announced the launch of STAgora, a next-generation infectious disease analytics platform designed to provide real-time epidemiological intelligence. The platform leverages PCR-derived diagnostic data to deliver immediate visualization of outbreak trends at municipal, national, and global levels. It combines structured diagnostic information with over 40 advanced statistical tools that facilitate early detection of unusual pathogen patterns, co-infections, and predictive modeling for seasonal and emerging outbreaks.1

How Does Seegene’s STAgora Platform Improve Real-Time Infectious Disease Tracking and Response?

"The key differentiator of STAgora is its unique architecture, which aggregates real-time diagnostic data from around the world into a unified analysis platform," said Young-Seag Baeg, head, strategic planning, Seegene, in a press release.

Advanced Analytics and AI Forecasting for Proactive Decision-Making

Seegene stated that STAgora supports proactive decision-making by employing AI-driven algorithms to forecast potential disease spread, setting it apart from traditional surveillance systems that primarily rely on retrospective data analysis. When paired with the company’s syndromic quantitative PCR technology, the platform provides detailed insights into both single-pathogen and multi-pathogen infections, offering valuable information to support clinical decision-making.

Upcoming Demonstrations and Integration with Cureca System

STAgora is slated to be showcased at the 2025 Association for Diagnostics & Laboratory Medicine (ADLM) annual meeting later this month. At ADLM, Seegene will demonstrate the platform’s core features, including its integration with Cureca, the company’s fully automated, unmanned PCR system.1

In May, Seegene presented a conceptual video of Cureca at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) conference. The system includes modular components such as the customizable pre-treatment system for specimen processing and the primary sample aliquot system for direct sample loading. At ESCMID, Seegene also introduced CEFA, a modular automation framework designed to offer flexibility in laboratory workflow configurations.2

Seegene first announced the development of Cureca in April.3

Vision for Molecular Diagnostics Automation and Public Health Preparedness

"Until now, there has been no system capable of fully automating pre-treatment processing for all specimen types, which has prevented true automation in MDx," said Jong-Yoon Chun, founder, CEO, Seegene, in a press release. "We aim to define a new global benchmark and help reshape the future of MDx."3

Supporting Public Health Infrastructure and Preparedness

With the launch of STAgora, Seegene aims to position the platform as a tool for enhancing real-time infectious disease monitoring and response. By integrating molecular diagnostic data with AI-powered analytics and global data sources, STAgora is intended to support the development of more responsive public health infrastructure. According to the company, the platform could become a vital component of broader efforts to improve diagnostic insight and preparedness for emerging health threats.1

"During the COVID-19 pandemic, we saw firsthand how crucial accurate and timely interpretation of diagnostic data was in shaping public health policies and clinical outcomes," said Daniel Shin, EVP, chief global sales and marketing officer, Seegene, in the press release. "Now, as we confront increasingly complex threats such as antimicrobial resistance, viral mutations and co-infections, the ability to deliver actionable insights from diagnostic data is becoming a cornerstone of clinical innovation and a vital pillar of global health security."

References

  1. Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics. PR Newswire. July 2, 2025. Accessed July 2, 2025. https://www.prnewswire.com/news-releases/seegene-launches-stagora-a-new-platform-for-infectious-disease-analytics-302495811.html
  2. Seegene's CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation. PR Newswire. May 2, 2025. Accessed July 2, 2025. https://www.prnewswire.com/news-releases/seegenes-curecatm-emerges-as-a-potential-game-changer-in-end-to-end-pcr-automation-302444915.html
  3. Seegene Announces Development of CURECA™, a Next-Generation Fully Automated PCR Solution Featuring Customizable Pre-treatment Automation. PR Newswire. April 9, 2025. Accessed July 2, 2025. https://www.prnewswire.com/news-releases/seegene-announces-development-of-cureca-a-next-generation-fully-automated-pcr-solution-featuring-customizable-pre-treatment-automation-302424433.html

Related to this article

View more
How QMM Can Help the C-Suite See a $100 Million Problem Early
How QMM Can Help the C-Suite See a $100 Million Problem Early
A passing FDA inspection tells pharma senior leadership very little about whether the next significant revenue vulnerability is already taking shape. But continuous, AI-enabled quality management maturity (QMM) has the potential to do so months before the issue reaches the realm of P&L.
Read more